Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 5081-5090 of 13612

Page
per page
  1. CB-839
    B4799 CB-839
     1 Citation
    Target: Glutaminases
    Summary: An orally active glutaminase inhibitor.
      ≥28.6 mg/mL
  2. Oxfendazole
    B1998 Oxfendazole
    Summary: broad spectrum benzimidazole anthelmintic
      insoluble in EtOH; insoluble in H2O; ≥15.75 mg/mL
  3. Glucosyl-vitexin
    N1397 Glucosyl-vitexin
      ≥29.75 mg/mL
  4. GPDA
    A4775 GPDA
    Summary: A substrate reagent for detecting prolyl dipeptidyl peptidase activity
      ≥54.1 mg/mL
  5. Mivebresib
    BA2770 Mivebresib
    Summary: Mivebresib (ABBV-075) is an effective.
  6. T025
    BA2818 T025
    Summary: T025 is an orally effective inhibitor.
  7. Lobaplatin
    BA2842 Lobaplatin
    Summary: Lobaplatin (D-19466) is an diastereomeric mixture of platinum(II) complexes.
  8. β-Pseudouridine
    B8649 β-Pseudouridine
     1 Citation
    Summary: The C-5 glycoside isomer of uridine
      ≥32.3 mg/mL
  9. N1-Methyl-2-deoxyadenosine
    BA4305 N1-Methyl-2-deoxyadenosine
    Summary: N1-Methyl-2'-deoxyadenosine,DNAadduct is a purine nucleoside analog.
  10. LAP
    BA9550 LAP
    Summary: LAP (Lithiumphenyl-2,4,6-trimethylbenzoylphosphinate) is a free radical initiator.
      ≥7.12 mg/mL

Items 5081-5090 of 13612

Page
per page